STOCK TITAN
  1. Home
  2. Sec-filings
  3. EKSO
  4. [Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity

[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Ekso Bionics Holdings, Inc. major shareholder Daniel Asher reported a series of indirect open-market purchases of common stock through DBA Trading, LLC between February 6 and February 13, 2026, at prices around the high-$8 to mid-$9 range per share.

Following these trades, DBA Trading, LLC held 258,792 shares of Ekso Bionics common stock indirectly for Asher, while he also reported 165,000 shares of common stock held directly. In addition, a trust for which Asher is grantor held 2,926 shares of convertible preferred stock, convertible into 355,960 shares of common stock, all reported as indirect beneficial ownership.

Positive

  • None.

Negative

  • None.
Insider ASHER DANIEL
Role 10% Owner
Bought 102,029 shs ($970K)
Type Security Shares Price Value
Purchase Common Stock 11,092 $9.1429 $101K
Purchase Common Stock 16,100 $8.9611 $144K
Purchase Common Stock 8,908 $9.1844 $82K
Purchase Common Stock 30,124 $9.688 $292K
Purchase Common Stock 20,611 $9.6924 $200K
Purchase Common Stock 10,200 $9.924 $101K
Purchase Common Stock 4,800 $9.9625 $48K
Purchase Common Stock 194 $9.8552 $2K
holding Convertible Preferred Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 242,692 shares (Indirect, by DBA Trading, LLC); Convertible Preferred Stock — 355,960 shares (Indirect, By Daniel Asher Descendants Trust); Common Stock — 165,000 shares (Direct)
Footnotes (1)
  1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them. None
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ASHER DANIEL
(Last) (First) (Middle)
1011 LAKE ST
SUITE 311
(Street)
OAK PARK IL 60301
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [ EKSO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/06/2026 P 194 A $9.8552 156,957 I by DBA Trading, LLC(1)
Common Stock 02/09/2026 P 4,800 A $9.9625 161,757 I by DBA Trading, LLC(1)
Common Stock 02/10/2026 P 10,200 A $9.924 171,957 I by DBA Trading, LLC(1)
Common Stock 02/11/2026 P 20,611 A $9.6924 192,568 I by DBA Trading, LLC(1)
Common Stock 02/12/2026 P 8,908 A $9.1844 201,476 I by DBA Trading, LLC(1)
Common Stock 02/12/2026 P 30,124 A $9.688 231,600 I by DBA Trading, LLC(1)
Common Stock 02/13/2026 P 11,092 A $9.1429 242,692 I by DBA Trading, LLC(1)
Common Stock 02/13/2026 P 16,100 A $8.9611 258,792 I by DBA Trading, LLC(1)
Common Stock 165,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Convertible Preferred Stock $8.22 01/22/2026 (3) Common Stock 355,960 2,926 I By Daniel Asher Descendants Trust(2)
Explanation of Responses:
1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.
2. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.
3. None
Daniel Asher 02/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR